Panagora Asset Management Inc Kezar Life Sciences, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.8 - $1.05 $119,295 - $156,574	149,119 Added 177.34%	233,206 $209,000
Q4 2023 Feb 08, 2024	BUY	$0.72 - $1.15 $60,542 - $96,700	84,087 New	84,087 $79,000
Q3 2021 Nov 10, 2021	SELL	$4.85 - $9.73 $8,191 - $16,433	-1,689 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$4.93 - $6.46 $384 - $503	-78 Reduced 4.41%	1,689 $9,000
Q4 2020 Feb 10, 2021	SELL	$4.77 - $6.58 $4,636 - $6,395	-972 Reduced 35.49%	1,767 $9,000
Q3 2020 Nov 13, 2020	SELL	$4.36 - $5.5 $13,158 - $16,599	-3,018 Reduced 52.42%	2,739 $13,000
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $12,971 - $26,927	4,683 Added 436.03%	5,757 $25,000
Q4 2019 Feb 12, 2020	BUY	$2.5 - $4.26 $2,685 - $4,575	1,074 New	1,074 $4,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.